Target intelligence / Profile preview

Protein transport protein Sec61 subunit alpha isoform 1 (SEC61A1)

Target
SEC61A1
Molecular classification
Translocon/channel protein, ER channel protein, Transporter, SecY/Sec61α family, Ribosome receptor
01

Overview

SEC61A1 encodes the alpha subunit of the SEC61 complex, a heteromeric protein channel anchored in the ER membrane. The Sec61 channel is the principal route for cotranslational and some posttranslational transport of secretory and transmembrane proteins into the ER, where they fold and mature. SEC61A1 also forms the ribosome receptor and a gated pore in the ER membrane, critical for correct targeting and movement of nascent polypeptides. The protein has ten transmembrane domains that create a central channel capable of dynamic opening and closing for substrate passage. SEC61A1 also controls passive ER Ca²⁺ leakage, contributing to cellular calcium balance and linking it to stress pathways such as the unfolded protein response. Pathogenic mutations in SEC61A1 are associated with genetic kidney diseases and immunodeficiencies, and the target is being explored for anticancer therapy via specific channel inhibitors.

Other names
Protein transport protein Sec61 subunit alpha isoform 1SEC61A1Sec61 alpha-1SEC61ASec61 alpha 1 subunitADTKD5CVID15HNFJ4HSEC61SEC61
02

Mechanism of action

Allosteric inhibition or blockage of the Sec61 channel, preventing protein translocation into the ER; Modulating ER calcium leakage and UPR (unfolded protein response)

03

Biological functions

Protein translocation across/insertion into the ER membraneRibosome binding and nascent peptide gatingRegulation of cellular calcium homeostasis (passive Ca²⁺ leak channel)Nephrogenesis (critical for kidney development)Participation in antigen processing pathways
04

Disease associations

Autosomal-dominant tubulo-interstitial kidney disease (ADTKD5)Common variable immunodeficiency (CVID15)Congenital neutropenia (SCN11)Cancer (mutations, amplifications, or overexpression in various tumors)Involvement in protein misfolding disorders due to ER stress
05

Safety considerations

Toxicity due to global disruption of ER protein translocation (potential for broad cellular effects)ER stress induction and cell death if translocon blocked universallyDisruption of calcium homeostasis may lead to multi-organ effects
06

Interacting drugs

Cotransin and related Sec61 inhibitors (experimental anticancer compounds)

1 more in the full profile.

07

Biomarkers

Mutations in SEC61A1 (e.g., for ADTKD and immunodeficiencies)Overexpression/alterations in SEC genes in cancer (studied as predictive markers)

Beyond the preview

Go deeper on Protein transport protein Sec61 subunit alpha isoform 1 (SEC61A1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein transport protein Sec61 subunit alpha isoform 1 (SEC61A1).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call